Conversation Starter: How To Convince Your Boss That Digital CMC Is Right for Your Team
Experts on the CMC data frontlines are quick to see the value of Digital CMC, but leadership might need some convincing. Here’s how to do it.
Data Governance and Integrity: Pharma, Biotech, and the Data Deluge, Part 4
In chapter 4 of our series on drug development data, Yash looks at a practical application of structured data principles: building a digital qTPP that supports automation of numerous CMC tasks.
Enabling Pre-commercial Product Lifecycle Management (PLM) for Pharma & Biotech
For drug developers, pre-commercial product lifecycle management (PLM) is quickly becoming essential for regulatory compliance and operational efficiency. Learn how digital CMC tools can enable it.
Getting Leaner, Going Digital: 4 Ways Drug Developers Are Adapting to a New Market
Drug developers are downsizing their way into a new era of efficiency. Here’s why they need digital infrastructure like QbDVision more than ever.
Data Governance and Integrity: Pharma, Biotech, and the Data Deluge, Part 3
Scrambling to consolidate CMC data often feels like a rite of passage for drug developers. But does it have to be that way? In post 3 of our series on data governance and integrity, Yash shares a modern, structured approach to managing CMC data.
New Updates to the FDA’s PAI Process Put Drug Developers on Notice
With the new CPMG Objective 4, the FDA has officially put knowledge management and QRM on the menu for PAI audits. So what does that mean for drug development programs?
Interview: Mike Stapleton Outlines His Vision for the Next Frontier of Digital Drug Development
A distinguished life science leader with more than 30 years of experience, Mike brings a wealth of expertise and a track record of success to his new board leadership role.
Three Ways Smart Content Authoring Accelerates CMC Workflows
Still struggling to hand-build regulatory submissions, cobble together tech transfers, and manually manage organizational knowledge? Find out how QbDVision’s latest Digital CMC tool transforms each of these time-consuming steps.
Six Trends That Will Define Digital Drug Development in 2024
New innovation, more challenges, and even bigger pressures: Here’s where digital drug development is headed next, from AI, to quality management, to nurturing digital culture, and beyond.
Drug Development’s Digital Leaders Reunite at the 2nd Annual Digital CMC Summit
For the second year in a row, technology innovators from across the life sciences flocked to Austin, TX, for this exclusive, one-of-a-kind conference experience. Stream all 9 sessions to see how drug development’s high-performance future is taking shape.
